Danish pharmaceutical giant Novo Nordisk is set to apply for t | ThePrint

Danish pharmaceutical giant Novo Nordisk is set to apply for the regulatory approval of its once-a-week insulin drug, Icodec, in the US, European Union and China, according to the company’s financial report for the first quarter of the current financial year, which was released last week.

https://bit.ly/3W0FGjQ